
Aytu Biopharma Investor Relations Material
Latest events

Q1 2025
Aytu Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Aytu Biopharma Inc
Access all reports
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company's revenue is derived from the United States sales force focused on urological and primary care markets; licensing rights to its intellectual property portfolio; development partnerships and licensing agreements with multiple cross-functional teams in product development, clinical development, business development professionals. It has approximately 9 products. Aytu Biopharma was incorporated in 2010 and is headquartered in Englewood, Colorado.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
AYTU
Country
🇺🇸 United States